Armistice Capital, LLC Lexaria Bioscience Corp. Transaction History

Armistice Capital, LLC

  • $5.71 Billion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$2.01 - $3.3 $924,599 - $1.52 Million
460,000 New
460,000 $970,000
Q2 2024

Aug 14, 2024
BUY
$1.99 - $4.0 $2.03 Million - $4.08 Million
1,020,000 New
1,020,000 $2.84 Million
Q3 2023

Nov 14, 2023
BUY
$0.72 - $1.11 $640,275 - $987,091
889,272 New
889,272 $889,000

Others Institutions Holding LEXX

# of Institutions
23
Shares Held
2.34M
Call Options Held
0
Put Options Held
0
View Full List

About Lexaria Bioscience Corp.

LEXX Quotes by TradingView
  • Ticker LEXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,951,000
  • Market Cap $4.94M
  • Description
  • Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...
More about LEXX
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email